Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medrox AB
AB
Active
Org 5591486419
Segelvägen 20
Medical specialists activities · NACE 8622
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 351K
-39% vs 2023
EBITDA margin
82.9%
-44% vs 2023
Equity ratio
84.4%
Financial strength
Net profit 2024
SEK 240K
-43% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2020
1M
0%
2021
0M
-100%
2022
1M
+100%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
SEK 351K
-39%
EBITDA
SEK 291K
-44%
Net profit
SEK 240K
-43%
Total assets
SEK 1,3M
-1%
Equity
SEK 1,1M
+2%
Employees
0
—
Company information
Legal name
Medrox AB
Org number
5591486419
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 februari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utbildning, forskning och medicinsk konsultation och därmed förenlig verksamhet.
Contact
Address
Segelvägen 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Varberg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
1M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
582
627
451
577
351
Staff expenses
—
—
—
—
—
EBITDA
501
553
385
521
291
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
501
553
385
521
291
Net financials
−1
−1
−1
5
10
Profit before tax
500
552
384
527
300
Tax
−107
−114
−79
−107
−60
Net profit
393
438
305
420
240
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
948
1 126
1 117
1 320
1 304
Equity
652
741
850
1 074
1 100
Long-term debt
0
0
0
0
0
Short-term debt
296
385
266
246
204
Total debt
296
385
266
246
204
Financial ratios
5-year trend
EBITDA margin
82.9%
This company
15.8%
Market median
+425% vs market
2020
2024
Equity ratio
84.4%
This company
38.2%
Market median
+121% vs market
2020
2024
Return on equity
21.8%
This company
18.4%
Market median
+18% vs market
2020
2024
Net profit margin
68.4%
This company
8.1%
Market median
+744% vs market
2020
2024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
2020
2024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EG
Eva Gertrud Persson
Deputy Board Member
2022
LI
Lennart Ingemar Roxvall
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Medrox AB also hold positions in
0
other companies.
Person
Role here
Other companies
Eva Gertrud Persson
Deputy Board Member
0 companies
Lennart Ingemar Roxvall
Board of Directors
0 companies